ArticleLiver cancer2026

Adverse Event Monitoring with Imaging: Prognostic Significance in Atezolizumab plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma.

Jeayeon Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.